Last edition
News about Industrial talks
Medtronic to invest Rs. 1,200 crore to expand its R&D centre in Hyderabad
With Hyderabad fast emerging as Indias hub for medical devices manufacturing, the US-based Medtronic has decided to further consolidate its base in India in the medical devices manufacturing sector. As part of this, the company has decided to invest Rs. 1,200 crore to scale up and expand its current R&D centre into a state-of-the-art engineering
Industrial talks | 17/08/2020 | By Darshana | 411
Amazon India unveils e:pharmacy platform in Bengaluru, pilots likely in other cities
The Amazon Pharmacy service has currently opened in Bengaluru. The company plans its foray into other metros thereafter. Customers can now order via its platform: amazon.in all medicines via prescription. In addition nutraceuticals supplements, Ayurveda medicines and medical devices can also be ordered
Industrial talks | 14/08/2020 | By Darshana | 340
Sanofi Canada announced that Health Canada has approved Sarclisa in combination with pomalidomide and dexamethasone for the treatment of adults with relapsed and refractory multiple myeloma (RRMM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor
Industrial talks | 10/07/2020 | By Darshana | 437
India announces collaboration with Australia for Covid-19
Prime Minister Narendra Modi and the Prime Minister of Australia, Scott Morrison MP, announced a COVID-19 collaboration in 2020 during an India-Australia leaders' virtual summit held on June 4, 2020
Industrial talks | 08/06/2020 | By Darshana | 530
NPPA issues list of revised MRPs to ensure compliance on price of N- 95 mask
To ensure the availability of N-95 masks at the revised MRPs as per price control compliance, the National Pharmaceutical Pricing Authority (NPPA) has issued a list of price reduction in N-95 masks by four major N-95 mask manufacturers, namely Venus Safety and Health Pvt Ltd, Magnum Health and Safety, Yash Care Life Sciences and Joseph Leslie & Co
Industrial talks | 08/06/2020 | By Darshana | 446
Glenmark Pharma to study potential Covid-19 drug combination
Glenmark Pharmaceuticals Ltd said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment
Industrial talks | 26/05/2020 | By Darshana | 408
Bayer has submitted an application for marketing authorization for its precision oncology treatment larotrectinib to the Ministry of Health, Labor and Welfare (MHLW) in Japan. Larotrectinib is an oral TRK inhibitor that has been developed specifically to treat adults and children
Industrial talks | 25/05/2020 | By Darshana | 504
Lupin's Pithampur Unit-1 facility receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1, India facility. The inspection for the facility was conducted by the U.S. FDA between February 3, 2020 and February 11, 2020
Industrial talks | 30/04/2020 | By Darshana | 474
Virtual Show: new technologies for solid dosage forms from Syntegon
From May 7 to 13, Syntegon Technology showcases its long-standing processing and packaging expertise for solid dosage forms at the Virtual Show. The new Sepion coater series, which is available in six sizes, marks the beginning of the novelties
Industrial talks | 29/04/2020 | By Darshana | 405
Bayer announced today its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) in launching a major clinical research program aimed at identifying potential treatments against COVID-19
Industrial talks | 22/04/2020 | By Darshana | 295
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy